Alzheimer's disease (AD) is the major cause of late-life brain failure. In the past 25 years,
autosomal dominant forms of AD were found to be primariy attributable to mutations in one …

Abstract Alzheimer's disease (AD), the leading cause of dementia, has reached epidemic
proportions, with major social, medical and economical burdens. With no currently available …

The field of Alzheimer disease (AD) prevention has been a culmination of basic science,
clinical, and translational research. In the past three years since the new 2011 AD diagnostic …

Background Numerous studies have investigated risk factors for Alzheimer disease (AD).
However, at a recent National Institutes of Health State-of-the-Science Conference, an …

Alzheimer's disease (AD) is a generalized term used for the loss in memory and other
intellectual abilities on levels serious enough to interfere with daily life. It accounts for 60 …

Alzheimer's disease is an unavoidable neurological disorder in which the death of brain
cells causes memory loss and cognitive decline and ultimate dementia. It is the most …

Alzheimer's disease (AD) is a neurodegenerative old age disease that is complex,
multifactorial, unalterable, and progressive in nature. The currently approved therapy …

Alzheimer's disease (AD) is an age-related progressive dementia, which is increasing in
prevalence world-wide. Typically affecting short-term memory at onset, this devastating …

Alzheimer's disease (AD) is the sixth-leading reason of fatality and is 70% present in all
cases of dementia. The global burden of AD is expected to accelerate from 26.6 million …

One of the major challenges of medical sciences has been finding a reliable compound for
the pharmacological treatment of Alzheimer's disease (AD). As most of the drugs directed to …